Applied DNA Sciences (NASDAQ:APDN) Posts Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Applied DNA Sciences (NASDAQ:APDN) released its earnings results on Tuesday. The technology company reported ($0.32) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.33) by $0.01, Zacks reports. Applied DNA Sciences had a negative return on equity of 138.41% and a negative net margin of 214.42%.

Applied DNA Sciences Stock Performance

APDN stock traded up $0.05 during mid-day trading on Tuesday, hitting $0.23. 30,165,006 shares of the company were exchanged, compared to its average volume of 4,134,912. Applied DNA Sciences has a 1-year low of $0.12 and a 1-year high of $14.40. The firm’s 50 day simple moving average is $0.22 and its 200 day simple moving average is $0.60. The firm has a market cap of $11.78 million, a P/E ratio of -0.02 and a beta of 0.46.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded shares of Applied DNA Sciences to a “sell” rating in a research report on Tuesday, September 17th.

About Applied DNA Sciences

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.